Applied Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch Applied Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Confirmatory Study of Govorestat in CMT-SORD (NCT07191912) | Applied Therapeutics, Inc. | 2026-05-01 |
| Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency (NCT05397665) | Applied Therapeutics, Inc. | 2022-01-01 |
| AT-007 in Adult Subjects With Classic Galactosemia (CG) (NCT05418829) | Applied Therapeutics, Inc. | 2021-10-01 |
| Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia (NCT04902781) | Applied Therapeutics, Inc. | 2021-03-20 |
| Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy (NCT04083339) | Applied Therapeutics, Inc. | 2019-09-20 |
| Safety and Pharmacokinetics of AT-007 in Healthy Subjects and in Adult Subjects With Classic Galactosemia (NCT04117711) | Applied Therapeutics, Inc. | 2019-06-21 |
Track Applied Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.